Hoxton Financial’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Hoxton Financial’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	$28K	Sell	540 -78,036	-99%	-$4.05M	0.01%	188
2015 Q4	$5.52M	Buy	78,576 +2,262	+3%	+$154K	2.69%	16
2015 Q3	$4.75M	Sell	76,314 -3,864	-5%	-$305K	2.26%	17
2015 Q2	$6.74M	Sell	80,178 -6,900	-8%	-$537K	2.8%	18
2015 Q1	$6.54M	Sell	87,078 -12,417	-12%	-$867K	2.78%	17
2014 Q4	$6.18M	Sell	99,495 -2,784	-3%	-$159K	2.58%	17
2014 Q3	$5.32M	Sell	102,279 -1,428	-1%	-$72.8K	2.33%	18
2014 Q2	$5.32M	Sell	103,707 -96,939	-48%	-$4.37M	2.27%	19
2014 Q1	$9.53M	Sell	200,646 -45,981	-19%	-$2.35M	4.03%	11
2013 Q4	$10.7M	Buy	+246,627	New	+$10.2M	4.62%	4
2013 Q3	–	Sell	-217,806	Closed	-$7.57M	–	618
2013 Q2	$7.57M	Buy	+217,806	New	+$7.65M	4.27%	12

Other funds holding XBI

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Hoxton Financial's XBI Position: Q1 2016 in Review

Hoxton Financial reduced its State Street SPDR S&P Biotech ETF (XBI) stake by 99% in Q1 2016, selling an estimated $4.05M and leaving 540 shares worth $28K. The position accounts for 0.01% of the portfolio, ranked #188.

Hoxton Financial first reported a position in XBI in Q2 2013 and has held it in 11 quarters since. The position peaked at $10.7M in Q4 2013. 195 funds tracked by Wall St. Rank hold XBI as of Q1 2016.

Hoxton Financial held 540 shares of State Street SPDR S&P Biotech ETF worth $28K as of Q1 2016.
Hoxton Financial sold 78,036 State Street SPDR S&P Biotech ETF shares in Q1 2016, an estimated $4.05M.
State Street SPDR S&P Biotech ETF made up 0.01% of Hoxton Financial's portfolio in Q1 2016, its #188 holding.
Hoxton Financial first reported a position in State Street SPDR S&P Biotech ETF in Q2 2013 and has held it in 11 quarters since.
Hoxton Financial's State Street SPDR S&P Biotech ETF position peaked at $10.7M in Q4 2013.
195 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q1 2016.

Based on Hoxton Financial's 13F filing for Q1 2016, filed 29 Apr 2016.